| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6B | $2.4B | $2.4B | $2.4B | $2.3B | $2.4B | $2.5B | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.3B | $0.3B | $0.4B | $0.4B | $0.3B | $0.0B | $0.1B | $0.1B |
| Net Income | $0.3B | $0.0B | $0.1B | $0.2B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $1.85 | $0.23 | $0.73 | $1.18 | $0.59 | $0.09 | $0.32 | $0.28 |
| EPS (Diluted) | $1.82 | $0.22 | $0.72 | $1.17 | $0.58 | $0.09 | $0.32 | $0.28 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.8B | $3.6B | $3.7B | $3.8B | $4.5B | $4.5B | $4.3B | $4.2B |
| Current Assets | $0.7B | $0.5B | $0.5B | $0.6B | $0.9B | $0.7B | $0.5B | $0.6B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.5B | $0.3B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.4B | $0.3B | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | $0.7B |
| Stockholders' Equity | $1.5B | $1.3B | $1.3B | $1.2B | $1.0B | $0.9B | $1.0B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.2B | $0.3B | $0.3B | $0.3B | $0.4B | $0.3B | $0.3B |
| Investing Cash Flow | $0.1B | $-0.1B | $-0.1B | $0.0B | $-0.1B | $-0.1B | $-0.1B | $-0.2B |
| Capital Expenditures | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B |
| Financing Cash Flow | $-0.2B | $-0.2B | $-0.2B | $-0.7B | $0.0B | $-0.1B | $-0.3B | $-0.1B |